THE
FUTURE
OF CANNABIS SCIENCE
The science behind every cannabis decision. Canalytics reads the lab reports the industry already produces and turns them into answers you can act on: what a product does, who it suits, what to grow and breed, what to stock, what to recommend, and which products fit specific effects, moods or activities. Eight connected apps, one engine, built on 10,213 peer-reviewed studies. For brands, breeders, cultivators, processors, labs, dispensaries, clinicians and researchers.
Cannabis Science,
Made Measurable
An AI model cannot fully show or reproduce the complex processes behind its responses. Ask it the same thing twice and you may get two different answers, with no way to check either one.
Canalytics is built the opposite way. Every score comes out of a fixed calculation, run on the chemistry in the lab report COA. Nothing is estimated and nothing is improvised. Score the same lab report COA tomorrow and you get the same numbers, because the same chemistry always produces the same result.
That is what lets one engine sit under a breeding decision, a purchase order, a marketing claim and a clinical recommendation. Evidence that holds still long enough to be checked.
Lab Report COA Input
The lab report you already have
Chemical Fingerprint
Every cannabinoid and terpene in the product analyzed by effect
Receptor Mapping
Compound modulation of receptors further drives effect profile
Effect Scores
13 effects, each scored 0 to 10
Solutions for the Entire Cannabis Industry
Canalytics turns decades of research into software built for each sector of the industry, so anyone, whatever their cannabis knowledge, can make science-backed decisions.
Brands
Know what your products do before you make them. Score every SKU by effect, find the product gaps and overlaps, and back every claim and recommendation with science. Show the evidence and you stop competing on buzzwords and THC %.
Dispensaries
Match every customer to something that actually works, online and at the counter. Shoppers name what they want to feel and what to avoid, and the shelf re-sorts. The right first purchase is what brings them back.
Cultivators
Decide what to grow with evidence instead of trends. Score every clone and seed line by effects, test a few seeds before committing a room, and turn every harvest lab report COA into an asset. Sell on effect coverage, not price per pound.
Processors & Manufacturers
Formulate toward an outcome instead of around whatever biomass is available. Score every input you hold or could buy, then find the combinations that rate highest for each line's target effects. Work on your whole catalog at once.
Testing Labs
Turn the lab report COA you already produce into the most valuable document in your client's business. Give every client a branded dashboard to view the effects of the lab report COAs you've analyzed for them, and grow one-off testing jobs into recurring work.
Breeders & Phenohunters
Simulate every possible cross and get predicted effect scores for each one in about 30 seconds. Once the offspring are grown, score the real phenotypes and rank them by their alignment with any effects, moods or activities.
Research & Universities
Start from a finished analytical foundation instead of building one from primary literature. Receptor-level pharmacology, cancer analytics, breeding simulation and a clinical layer. Reproducible, and ready on day one.
Clinicians & Clinics
Recommend with evidence instead of instinct. One intake scores every in-stock product against each condition, flags drug interactions and contraindications, and includes dosing guidance. HIPAA-grade, with or without an EMR.
Pharmaceutical
Deploy pharmaceutical-depth analytics on day one instead of building them over years. Specify your target effects, score chemovars by match, screen the plant universe for the closest natural fit, and standardize every trial site.
Eight Apps. One Scientific Engine.
Every Canalytics app draws on the same scoring engine, so data moves between them without friction. A phenotype scored by effect in Canalytics becomes a product that can be matched to what a brand or a customer is actually trying to achieve. Business and Breeding decide what gets grown, bought and sold. Shop personalizes ecommerce and in-store recommendations around each customer's needs, and Marketing shows the right audience why a product's effects fit what they are looking for. The same scores carry the whole way. Deploy one Canalytics app or the full suite.
Canalytics Shop
Every product in stock gets a personal match score based on the effects, moods or activities each customer asks for, and the catalog re-sorts as the shopper changes what they want. Filter for calm without couchlock. Describe what you are after in plain English and personalized product recommendations. A chat assistant trained on 10,000+ studies is available 24/7, alongside a time-of-day smart cart, demand intelligence and easy POS API integration.
Canalytics Business
Lab report COAs sync in automatically through Dutchie and 8 other POS integrations, and you can upload a lab report COA PDF or photograph one from any lab. Inside: effect scoring, side-by-side strain comparison across multiple tabs, effect-based search, buyer personas, infusion pairings and a full B2B procurement system. Field Mode handles buying in-person. Remote Analysis Mode handles supplier lab report COAs from your desk.
Canalytics Audit
Turns a list of SKUs into something you can analyze. An automated multi-chapter audit covering inventory strength, effect coverage, quality, optimization, customer targeting, competitive position and what to do next. Plus gap analysis, price elasticity, revenue simulation and multi-location comparison.
Canalytics Breeding
Simulates every possible parent cross and ranks the predicted offspring by effect profile in 30 seconds. Optimize for several effects, moods and activities at once, and find the ideal parent ratio for any breeding project. Then analyze and score the resulting offspring from a phenohunt to see which parents and which breeding strategies actually met the goal.
Canalytics Plant Match
Give it a target profile and it searches any genetic library for the closest chemical match. The target can be your best seller, a competitor's sample, a pharmaceutical spec, or a designer profile reverse-engineered from clinical research and licensed from Canalytics. Weighted similarity scoring, with a compound-by-compound breakdown.
Canalytics Marketing
Coming SoonScores every piece of content against the effect analysis of a product's real chemistry and the buyer personas built from it, reads its emotional fingerprint, helps rewrites for tone and persuasion, and assembles multi-platform campaigns in minutes. Every claim tied back to the effect profiles and aligned audiences.
Cannabis Clinical Suite
Coming SoonA matching engine, not a treatment. From a structured patient intake, it ranks every available cannabis product by how closely its cannabinoid and terpene profile lines up with what 10,000+ peer-reviewed studies associate with that patient's stated needs. Under 60 seconds. Drug interaction and contraindication flags, dosing guidance and a rationale you can put in the chart. HIPAA-grade, and it does not need your EMR.
Canalytics Cancer Analytics
Coming SoonScores cannabis chemovars across multiple weighted pathways and cancer types, showing which cannabinoid and terpene profiles clinical research most consistently associates with each category. Includes documented synergy modeling, ML clustering, dimensionality reduction and feature importance analysis. Built for cancer support clinics, palliative networks, research programs, brands, and pharmaceutical development.
Plug Into the Stack You Already Run
Connect your POS, ecommerce, and API systems in minutes. Nothing to replace. Nothing to export by hand.
Dutchie
POS, Ecommerce & PaymentsConnect your Dutchie account and put your menu, inventory and sales data to work across every Canalytics app.
Canalytics
Jane
Sweed
Cova
Meadow
BioTrack
Alpine IQ
Connect
Authorize your existing account in a few clicks.
Sync
Inventory, product and sales data flow in automatically.
Analyze
Insights go live across your Canalytics tools.
Running a platform not listed? Ask about a custom integration
Scored on What It Actually Does
Every product Canalytics analyzes is scored across 13 therapeutic and adult use effects on a 0 to 10 scale, from the full cannabinoid and terpene fingerprint in its lab report COA. This is the shared vocabulary that lets a breeder target an effect, a dispensary sort a shelf by it, a marketer write to it, and a clinician recommend against it.
Therapeutic Effects Analyzed
Condition-relevant effects scored from 10,000 studies and receptor-level pharmacology, so clinical positioning and evidence-aligned recommendations rest on science.
Adult Use Effects Analyzed
Experience-relevant effects that predict how a product actually feels, so customers can shop by outcome instead of by strain name and THC percentage.
Plus 17 Additional Effect Categories
Version 2 of the Canalytics effect analysis engine will add 17 more effect categories to the 13 available today.
0 to 10 Scale
Effects are measured, not described. That makes products sortable, comparable and rankable against any set target.
Counter-Effect Filtering
Find high calm with low couchlock, or focus without sleepy effects. Score for what you want and against what you do not.
Receptor-Level Mapping
Cannabinoids and terpenes mapped to CB1, CB2, TRPV1, 5-HT1A, PPARγ, opioid μ and more, so scores rest on mechanism.
Robust Study Database
Every score is supported by a robust database of peer-reviewed studies and every calculation traceable. No black box analysis.
One Engine, Every Stage of the Supply Chain
Right now, each stage of the cannabis industry speaks its own language. Breeders talk in lineage. Growers talk in yield. Buyers talk in price per pound. Budtenders talk in strain names. Nothing carries forward, so every stage starts guessing again.
Canalytics gives all of them the same language: what the product does, scored the same way every time.
Breeders simulate crosses before a seed goes in soil. Growers commit rooms to what demand actually asks for, not to what sold last year. Processors formulate to a target and check every batch against it. Labs turn a one-off testing fee into an ongoing intelligence service. Dispensaries and brands match each customer to something that works, then stock and market from evidence. Clinicians recommend with per-condition scoring and interaction screening built in.
Peer-reviewed cannabis research encoded into a proprietary scoring engine, continuously expanded
Therapeutic and adult use effects scored on every product on a 0 to 10 scale
Certificates of Analysis converted into scored, sortable, comparable chemistry assets
Every Interaction Makes
the Whole System Smarter
Canalytics is a loop, not a toolbox.
What customers ask for flows back to what gets bred and grown. What gets bred and grown shapes what gets formulated and stocked. What gets stocked determines what each customer and patient is matched to. Then what actually worked for them flows back to the start, sharpening every prediction that follows.
Consumer Demand Signals
Effect-based tracking, chat assistant consultations, persona clustering and purchase likelihood show what customers and patients are really looking for.
Genetic Selection
Breeders and growers choose what to develop, with that demand evidence feeding Breeding simulations and Plant Match targets.
Product Creation
Brands and processors formulate and stock against documented demand, using Audit intelligence and Business procurement.
Personalized Matching
Shop, Marketing and the Clinical Suite match the right product to each need.
Outcome Tracking
How each person responds to specific cannabinoid and terpene profiles gets tracked, and those results feed straight back into stage one.
Designer Cannabis Formulas
100+ scientifically engineered effect profiles. License, partner, or purchase.
Most cannabis products start with available material and hope for a good outcome. This works the other way around.
Canalytics has reverse-engineered more than 100 precise cannabinoid and terpene formulas from 10,213 studies, each one built to hit a specific effect profile. You start from a documented target and build toward it. Formulate a concentrate, edible, tincture, vape or topical to the profile, or use Plant Match and Breeding to find and grow flower genetics that already match it.
Every formula is defined by chemistry, scored across all effects, and supported by the research behind it.
License
Take a formula for a product line, a format or a market, and launch with a documented effect profile from day one.
Partner
Build it with the Canalytics scientific team, from target spec through genetic sourcing, formulation and batch validation.
Purchase
Buy a formula outright for exclusive use in your category or region, and own a chemistry asset nobody else can sell.
Evening Calm, Daytime Clear
Persona: Calm-Seeking Professional
Illustrative values shown. Actual formulas are defined by full cannabinoid and terpene specifications.
Pharmaceutical-depth, from day one
If you are developing a cannabis-derived therapeutic against a specific clinical indication, there is a dedicated engagement tier. Target chemovar specification at pharmaceutical depth, multi-pathway cancer analytics, breeding direction, IND-supporting documentation, and direct work with our scientific team.
The People Behind the Engine
Canalytics was built by people who have spent their careers on opposite ends of the same problem. On one side, two decades of research into the endocannabinoid system and the ways cannabinoids and terpenes work together, distilled into the scoring and analysis engine every Canalytics app runs on. On the other, 23 years building labs, cultivation facilities, dispensaries and brands, learning firsthand what the industry needs and where it guesses. Between them sits a scientific advisory board of board-certified physicians practicing cannabinoid medicine, who ensure that every score, recommendation, and formula produced by the Canalytics engine is grounded in rigorous empirical research and analysis. Research that has to survive in the real world, and operators who insist on evidence.
Matthew Widmer
Matthew brings over two decades of extensive research and technological innovation to Canalytics. His multidisciplinary background in neuroscience, cognitive science, and computer science, and comprehensive analysis of 10,000+ studies on the endocannabinoid system and cannabinoid-terpene effect synergy provide a robust scientific foundation for Canalytics' cutting-edge algorithmic analysis systems. Matthew brings an impressive track record in designing sophisticated computational systems. In 2007, he spearheaded the development of a Crestron automation system with 5,000+ relays. Throughout his career, Matthew has been at the forefront of advancements ranging from digital therapeutics and VR/AR to innovative health-boosting systems utilizing emotion tracking feedback loops for personalized recommendations.
Brent Stevens
Brent Stevens, co-founder of Flower Mill and Canalytics, brings 23 years of expertise in the cannabis industry, spanning innovative product development, building labs, cultivation facilities, dispensaries, managing medical grows and founding multiple global brands. Including founding, patenting and spearheading the award-winning Flower Mill company, now a staple in the industry. With a background in c-suite company development and sales, Brent also founded The Shire Group, streamlining operations and compliance for businesses. Committed to social responsibility, he supports initiatives providing cannabis to communities in need. Brent's laser focus on improving cannabis quality and experience across therapeutic and adult use cannabis has driven advancements shaping the industry.
Dr. Janice Knox, MD, MBA
Dr. Janice Vaughn-Knox, MD, MBA is a retired board certified anesthesiologist, endocannabinologist, and certified cannabinoid medicine specialist. Dr. Janice is one of a family of 4 clinicians that believes science, research and technology will disrupt health care as it has been known. The future of cannabis medicine will depend on how well the physiology of the body is known and the correct clinical application of the pharmacology of cannabis and other botanicals.
Dr. Jessica Knox, MD, MBA, MPH
Dr. Jessica Knox is a board-certified preventive medicine physician with 6 years of clinical experience in cannabinoid medicine. Dr. Jessica is a co-founder of several organizations, including co-founder of Doctors Knox, Inc. and Pivital Holdings; and the Association for Cannabis Health Equity and Medicine (ACHEM), the first national medical association for BIPOC professionals seeking to heal themselves and their communities through cannabis education, advocacy, and application.
Dr. Rachel Knox, MD, MBA
Dr. Rachel Knox, MD, MBA is an endocannabinologist specializing in cannabinoid medicine, and a policy expert on cannabis and psychedelic health equity. She's the creator and president of the Cannabis Health Equity Movement (CHEM)®, comprising the Association for Cannabis Health Equity and Medicine (ACHEM), CHEM Allyance, and CHEM Cooperative; and is co-founder of Doctors Knox, Inc. and Pivital Holdings. She is the immediate past chair of the Oregon Cannabis Commission, immediate past Vice Chair and Equity Chair of the Oregon Psilocybin Advisory Board, and a founding board member of Cannabis Regulators of Color Coalition (CRCC).
Dr. David Knox, MD
Dr. David Knox is a board certified emergency medicine physician with nearly a decade of clinical experience in cannabinoid medicine. Along with his family, Dr. David founded Doctors Knox, Inc., the American Cannabinoid Clinics, delivering precision cannabinoid medicine to patients; and Pivital Edu, which develops comprehensive training for healthcare professionals in the ECS, endocannabinology and cannabinology.
Doctor Testimonials
“Canalytics is the realization of my vision for the cannabis industry, which is why I am thrilled to join the company's Scientific Advisory Board. Canalytics is pioneering the integration of science, physiology, and technology to deliver data-backed solutions targeting medical conditions, exactly what I've been eagerly anticipating for the past decade. Their technology eliminates guesswork for the entire supply chain by illuminating the intricacies of cannabis' effects.”
“As an endocannabinologist, I'm excited to contribute expertise to Canalytics' Scientific Advisory Board, driving innovation and impact. Canalytics adeptly combines scientific rigor with innovation illuminating cannabis' complexities through proprietary tech. This enables unprecedented customization - from breeding, product develop, product recommendations to novel formulations and increased efficacy in cannabis medicine.”
“Cannabis is a polypharmacy with multiple cannabinoids, terpenes, and phytochemicals. Precision in clinical use has been an issue, addressed through trial-and-error to find optimal results per patient. Canalytics' integration of science and technology offers great potential for a better approach to personalized botanical medicine.”
“Canalytics delivers a groundbreaking solution that clinical endocannabinologists have long awaited - sophisticated tech offering novel insights into diverse phytochemicals and their impact on human physiology. This unlocks the potential of personalized botanical medicine and self-care at an unprecedented scale. I am honored to help guide the development and deployment of this revolutionary technology.”
Let's Show You What's Possible
Bring us your situation and we will walk through it live. One dispensary or a national chain, a brand, a breeding program, a testing lab, a clinic or a research institution. We will show you exactly what changes in your operation.
App Demo
A live walkthrough, tailored to your industry, your use case and your operational context.
SaaS Service Options
Subscription options run against your real lab report COAs, your real inventory, your real customers or your real clinical workflow. Add apps as you need them.
Pharma-Grade Tier
Designer Cannabis Formulas for pharmaceutical partners, brands and manufacturers who need pharmaceutical-depth chemovar specification and multi-pathway analytics.